Proton pump inhibitors and the risk of pneumonia: A comparison of cohort and self-controlled case series designs

BMC Medical Research Methodology

Volumn 13, Issue 1, 2013, Pages

  Ramsay, Emmae N ^a,b   Pratt, Nicole L ^b   Ryan, Philip ^a   Roughead, Elizabeth E ^b  

^a UNIVERSITY OF ADELAIDE   (Australia)

^b UNIVERSITY OF SOUTH AUSTRALIA   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

PROTON PUMP INHIBITOR;

ARTICLE; AUSTRALIA; CHEMICALLY INDUCED DISORDER; COHORT ANALYSIS; COMPARATIVE STUDY; FEMALE; HOSPITALIZATION; HUMAN; MALE; METHODOLOGY; MORTALITY; PNEUMONIA; RISK; VERY ELDERLY;

AGED, 80 AND OVER; COHORT STUDIES; FEMALE; HOSPITALIZATION; HUMANS; MALE; PNEUMONIA; PROTON PUMP INHIBITORS; RESEARCH DESIGN; RISK; SOUTH AUSTRALIA;

EID: 84879218774     PISSN: None     EISSN: 14712288     Source Type: Journal    
DOI: 10.1186/1471-2288-13-82     Document Type: Article

References (19)

1. The case-crossover study design in pharmacoepidemiology. Suissa S, Delaney J, Stat Methods Med Res 2009 18 53 65 10.1177/0962280208092346 18765504
2. Tutorial in Biostatistics: the self-controlled case series method. Whitaker HJ, Farrington CP, Spiessens B, Musonda P, Stat Med 2006 25 10 1768 1797 10.1002/sim.2302 16220518
3. The methodology of self-controlled case series studies. Whitaker HJ, Hocine MN, Farrington CP, Stat Methods Med Res 2009 18 7 26 10.1177/ 0962280208092342 18562396
4. Four different study designs to evaluate vaccine safety were equally validated with contrasting limitations. Glanz J, McClure D, Xu S, Hambidge S, Lee M, Kolczak M, et al. JCE 2006 59 808 818 16828674 (Pubitemid 43996937)
5. Unintended effects of statins in men and women in England and Wales: population based cohort study using the QResearch database. Hippisley-Cox J, BMJ 2010 340 2197 10.1136/bmj.c2197 20488911
6. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Gulmez S, Holm A, Frederiksen H, Jensen T, Pedersen C, Hallas J, Arch Intern Med 2007 167 9 950 955 10.1001/archinte.167.9.950 17502537 (Pubitemid 46762758)
7. Risk of community-acquired pneumonia and use of gastric acid-suppressive drugs. Laheij R, Sturkenboom M, Hassing R, Dieleman J, Stricker B, Jansen J, JAMA 2004 292 16 1955 1960 10.1001/jama.292.16.1955 15507580 (Pubitemid 39411203)
8. Use of acid-suppressive drugs and risk of pneumonia: systematic review and meta-analysis. Eom C-S, Jeon C, Lim J-W, Cho E-G, Park SM, Lee K-S, CMAJ 2011 183 3 310 319 21173070
9. Initiation and duration of proton pump inhibitors in the Australian veteran population. Gadzhanova SV, Roughead EE, Mackson JM, Intern Med J 2012 42 E68 73
10. Immortal time bias in pharmacoepidemiology. Suissa S, Am J Epidemiol 2008 167 4 492 9 10.1093/aje/kwm324 18056625 (Pubitemid 351264145)
11. Australian Bureau of Statistics (ABS), Information paper: census of population and housing Canberra: ABS Socio-economic indexes for areas, Australia, 2001 ABS cat. no. 2039.0. 2003
12. Construction and characteristics of the RxRisk-V: a VA-adapted pharmacy-based case-mix instrument. Sloan KL, Sales AE, Liu CF, Fishman P, Nichol P, Suzuki NT, et al. Med Care 2003 41 6 761 74 PubMed PMID: 12773842 12773842
13. Longitudinal analysis of the costs associated with inpatient initiation and subsequent outpatient continuation of proton pump inhibitor therapy for stress ulcer prophylaxis in a large managed care organisation. Thomas L, Culley E, Gladowski P, Goff V, Fong J, Marche S, J Manag Care Pharm 2010 16 2 122 29 20178397
14. Long-term use of acid suppression started inappropriately during hospitalization. Zink DA, Pohlman M, Barnes M, Cannon ME, Aliment Pharmacol Ther 2005 21 1203 9 10.1111/j.1365-2036.2005.02454.x 15882240 (Pubitemid 40733485)
15. Semiparametric analysis of case series data. Farrington C, Whitaker H, Appl Statist 2006 55(Part 5) 553 94 (Pubitemid 44601378)
16. Self-controlled case series analysis with event-dependent observation periods. Farrington C, Anaya K, Whitaker HJ, Hocine M, Douglas I, Smeeth L, American Journal of Statistical Association 2011 106 494 417 26 10.1198/jasa.2011.ap10108
17. Case series analysis for censored, perturbed or curtailed post-event exposures. Farrington CP, Whitaker HJ, Hocine MN, Biostatistics 2009 10 1 3 16 18499654 (Pubitemid 352847902)
18. Gastric acid-suppressive therapy and community-acquired respiratory infections. Laheij RJ, Van Ijzendoorn MC, Janssen MJ, Jansen JB, Aliment Pharmacol Ther 2003 18 8 847 51 PubMed PMID: 14535879 10.1046/j.1365-2036.2003. 01744.x 14535879 (Pubitemid 37323651)
19. Use of proton pump inhibitors and the risk of community-acquired pneumonia: a population-based case-control study. Gulmez SE, Holm A, Frederiksen H, Jensen TG, Pedersen C, Hallas J, Arch Intern Med 2007 167 9 950 5 PubMed PMID: 17502537 10.1001/archinte.167.9.950 17502537 (Pubitemid 46762758)